209
Participants
Start Date
August 31, 2012
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
LCL161
LCL161 was available as 300 mg, tablets, which was supplied in child-resistant bottles.
paclitaxel
"Commercially available paclitaxel was sourced locally by each study site. Generic paclitaxel could be used for study treatment.~iv 80mg/m2"
Novartis Investigative Site, Dublin
Novartis Investigative Site, Taipei
Novartis Investigative Site, Nedlands
Novartis Investigative Site, Taipei
Novartis Investigative Site, Berlin
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Kiel
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Kuei-Shan Chiang
H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt SC, Tampa
Novartis Investigative Site, Padua
Vanderbilt University Medical Center Vanderbilt - Thompson Ln, Nashville
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Seville
Ohio State Comprehensive Cancer Center/James Cancer Hospital Ohio State, Columbus
Novartis Investigative Site, Essen
Novartis Investigative Site, Valencia
Novartis Investigative Site, Valencia
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Brno
Novartis Investigative Site, Heidelberg
Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville
Baylor College of Medicine Dept of Oncology, Houston
Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5), San Antonio
Novartis Investigative Site, München
Memorial Sloan Kettering Cancer Center Dept Onc, New York
Cedars Sinai Medical Center SC, Los Angeles
University of California at Los Angeles UCLA SC, Los Angeles
Novartis Investigative Site, Erlangen
Stanford University Medical Center Stanford, Stanford
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Yale University School of Medicine Yale Univ, New Haven
Massachusetts General Hospital Mass General 2, Boston
University of Wisconsin / Paul P. Carbone Comp Cancer Center Univ Wisc 2, Madison
Novartis Investigative Site, Itajaí
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Olomouc
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Dublin
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Brighton
Novartis Investigative Site, Kingston upon Thames
Novartis Investigative Site, Sutton
Novartis Investigative Site, London
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY